Nifty
Sensex
:
:
10763.40
35774.88
81.20 (0.76%)
317.72 (0.90%)

Pharmaceuticals & Drugs

Rating :
54/99

BSE: 532815 | NSE: SMSPHARMA

67.85
-0.50 (-0.73%)
19-Nov-2018 | 3:56PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  69.95
  •  69.95
  •  67.50
  •  68.35
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  16953
  •  11.50
  •  116.70
  •  60.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 574.36
  • 12.90
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 707.78
  • 0.37%
  • 1.79

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.27%
  • 3.48%
  • 25.57%
  • FII
  • DII
  • Others
  • 0.02%
  • 0.00%
  • 3.66%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 7.27
  • -0.78
  • -6.20

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.83
  • 10.28
  • 0.91

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 20.44
  • 14.69
  • -0.96

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.77
  • 15.39
  • 17.36

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.65
  • 2.13
  • 2.53

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 15.53
  • 9.45
  • 9.43

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 07
Net Sales
-
504.68
445.49
611.53
199.84
Net Sales Growth
-
13.29%
-27.15%
206.01%
 
Cost Of Goods Sold
-
289.90
295.85
385.15
109.95
Gross Profit
-
214.78
149.64
226.38
89.88
GP Margin
-
42.56%
33.59%
37.02%
44.98%
Total Expenditure
-
411.34
370.35
522.32
150.38
Power & Fuel Cost
-
22.57
18.23
33.81
8.95
% Of Sales
-
4.47%
4.09%
5.53%
4.48%
Employee Cost
-
32.80
26.92
38.11
5.81
% Of Sales
-
6.50%
6.04%
6.23%
2.91%
Manufacturing Exp.
-
12.14
10.35
37.94
7.31
% Of Sales
-
2.41%
2.32%
6.20%
3.66%
General & Admin Exp.
-
7.67
9.00
10.51
3.36
% Of Sales
-
1.52%
2.02%
1.72%
1.68%
Selling & Distn. Exp.
-
45.34
9.67
15.99
10.41
% Of Sales
-
8.98%
2.17%
2.61%
5.21%
Miscellaneous Exp.
-
0.91
0.33
0.80
4.59
% Of Sales
-
0.18%
0.07%
0.13%
2.30%
EBITDA
-
93.34
75.14
89.21
49.46
EBITDA Margin
-
18.49%
16.87%
14.59%
24.75%
Other Income
-
2.39
1.45
3.61
3.03
Interest
-
15.48
15.82
17.11
8.23
Depreciation
-
19.90
19.18
19.43
4.58
PBT
-
60.35
41.58
56.27
39.67
Tax
-
19.89
5.97
14.63
14.20
Tax Rate
-
32.96%
14.36%
26.00%
35.80%
PAT
-
40.45
35.61
41.64
25.47
PAT before Minority Interest
-
40.45
35.61
41.64
25.47
Minority Interest
-
0.00
0.00
0.00
0.00
PAT Margin
-
8.01%
7.99%
6.81%
12.75%
PAT Growth
-
13.59%
-14.48%
63.49%
 
Unadjusted EPS
-
3.75
3.37
4.83
25.46

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 07
Shareholder's Funds
284.49
254.74
293.60
192.08
Share Capital
8.47
8.47
8.47
10.00
Total Reserves
276.02
246.28
285.14
182.07
Non-Current Liabilities
96.58
91.41
161.56
88.21
Secured Loans
70.20
73.02
109.58
65.92
Unsecured Loans
1.20
1.20
3.64
6.95
Long Term Provisions
2.18
1.35
3.43
0.00
Current Liabilities
134.46
156.00
200.43
49.03
Trade Payables
38.70
66.75
84.40
23.86
Other Current Liabilities
23.48
19.95
40.37
0.33
Short Term Borrowings
58.40
59.76
72.75
0.00
Short Term Provisions
13.88
9.54
2.90
24.84
Total Liabilities
515.53
502.15
655.59
329.32
Net Block
279.26
290.45
370.35
68.84
Gross Block
318.34
309.63
500.81
96.16
Accumulated Depreciation
39.08
19.18
130.46
27.32
Non Current Assets
334.04
335.80
408.04
83.85
Capital Work in Progress
8.20
7.76
12.80
15.02
Non Current Investment
28.38
29.10
20.51
0.00
Long Term Loans & Adv.
16.19
6.58
4.37
0.00
Other Non Current Assets
2.01
1.90
0.00
0.00
Current Assets
181.49
166.36
247.55
233.89
Current Investments
0.00
0.00
0.00
0.03
Inventories
107.48
92.52
112.68
49.57
Sundry Debtors
24.15
21.32
61.09
59.98
Cash & Bank
12.71
12.37
15.08
95.71
Other Current Assets
37.15
28.48
35.21
1.81
Short Term Loans & Adv.
15.06
11.67
23.49
26.79
Net Current Assets
47.03
10.36
47.13
184.86
Total Assets
515.53
502.16
655.59
329.31

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 07
Cash From Operating Activity
31.81
73.47
61.22
14.33
PBT
60.35
41.58
56.27
39.67
Adjustment
31.08
31.58
28.14
18.09
Changes in Working Capital
-48.48
9.40
-1.17
-29.61
Cash after chg. in Working capital
42.95
82.56
83.24
28.16
Interest Paid
0.00
0.00
0.00
0.00
Tax Paid
-11.14
-9.09
-22.02
-5.60
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
Cash From Investing Activity
-16.58
-38.96
-96.72
-31.70
Net Fixed Assets
-9.15
128.49
-346.44
Net Investments
-8.02
-15.71
-17.94
Others
0.59
-151.74
267.66
Cash from Financing Activity
-14.89
-33.19
44.34
106.55
Net Cash Inflow / Outflow
0.35
1.32
8.84
89.18
Opening Cash & Equivalents
12.29
11.25
2.41
6.53
Closing Cash & Equivalent
12.63
12.29
11.25
95.71

Financial Ratios

Standalone /

Consolidated
Description
Mar 18
Mar 17
Mar 16
Mar 07
Book Value (Rs.)
33.61
30.09
34.68
18.05
ROA
7.95%
6.15%
8.46%
7.73%
ROE
15.00%
12.99%
17.57%
14.11%
ROCE
18.17%
12.73%
19.54%
18.91%
Fixed Asset Turnover
1.61
1.12
2.11
2.24
Receivable days
16.37
33.12
35.09
101.66
Inventory Days
72.01
82.47
47.02
84.02
Payable days
42.41
71.90
36.96
57.46
Cash Conversion Cycle
45.97
43.69
45.14
128.22
Total Debt/Equity
0.51
0.59
0.70
0.40
Interest Cover
4.90
3.63
4.29
5.82

Annual Reports:

News Update:


  • SMS Pharmaceuticals - Quarterly Results
    10th Nov 2018, 15:46 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.